About this document
Macrophage EVs for TNBC Drug Delivery by nonhle dlamini is a document available to read on EtoBox.
This study explores the use of macrophage-derived extracellular vesicles (EVs) as drug delivery systems for treating triple negative breast cancer (TNBC) by effectively targeting cancer cells with chemotherapeutics like paclitaxel and doxorubicin. The researchers developed and characterized novel EV-based formulations that demonstrated high drug loading and significant anti-proliferation effects in vitro and in vivo, leading to reduced tumor growth in mouse models. The findings suggest that EV-based drug de
- Author
- nonhle dlamini
- Language
- EN